Mesguich C[au] - Search Results

Year	Number of Results
2014	1
2015	2
2016	3
2017	6
2018	4
2019	3
2020	5
2021	2
2023	3
2024	1

1

Mesguich C, Hulin C, Lascaux A, Bordenave L, Marit G, Hindié E. Mesguich C, et al. Cancers (Basel). 2020 May 28;12(6):1394. doi: 10.3390/cancers12061394. Cancers (Basel). 2020. PMID: 32481661 Free PMC article. Review.

2

Advanced Hodgkin's lymphoma: End-of-treatment FDG-PET should be maintained.

Hindié E, Mesguich C, Bouabdallah K, Milpied N. Hindié E, et al. Among authors: mesguich c. Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1254-1257. doi: 10.1007/s00259-017-3714-4. Eur J Nucl Med Mol Imaging. 2017. PMID: 28466283 No abstract available.

3

Dual-tracer 99mTc-sestamibi/ 123I imaging in primary hyperparathyroidism.

Tlili G, Mesguich C, Gaye D, Tabarin A, Haissaguerre M, Hindié E. Tlili G, et al. Among authors: mesguich c. Q J Nucl Med Mol Imaging. 2023 Jun;67(2):114-121. doi: 10.23736/S1824-4785.23.03509-4. Epub 2023 Feb 7. Q J Nucl Med Mol Imaging. 2023. PMID: 36748984 Free article.

4

PET-guided, BEACOPP_escalated therapy in advanced Hodgkin lymphoma.

Mesguich C, Milpied N, Hindié E. Mesguich C, et al. Lancet Oncol. 2019 Apr;20(4):e189. doi: 10.1016/S1470-2045(19)30162-7. Lancet Oncol. 2019. PMID: 30942176 No abstract available.

5

New Perspectives Offered by Nuclear Medicine for the Imaging and Therapy of Multiple Myeloma.

Mesguich C, Zanotti-Fregonara P, Hindié E. Mesguich C, et al. Theranostics. 2016 Jan 1;6(2):287-90. doi: 10.7150/thno.14400. eCollection 2016. Theranostics. 2016. PMID: 26877786 Free PMC article.

6

State of the art imaging of multiple myeloma: comparative review of FDG PET/CT imaging in various clinical settings.

Mesguich C, Fardanesh R, Tanenbaum L, Chari A, Jagannath S, Kostakoglu L. Mesguich C, et al. Eur J Radiol. 2014 Dec;83(12):2203-2223. doi: 10.1016/j.ejrad.2014.09.012. Epub 2014 Sep 28. Eur J Radiol. 2014. PMID: 25308249 Review.

7

Interim PET Assessment of Advanced Hodgkin Lymphoma: Is It Sufficient?

Mesguich C, Bouabdallah K, Bordenave L, Milpied N, Hindié E. Mesguich C, et al. J Nucl Med. 2020 Nov;61(11):1694-1695. doi: 10.2967/jnumed.120.242594. Epub 2020 Feb 14. J Nucl Med. 2020. PMID: 32060220 Free article. No abstract available.

8

Improved 18-FDG PET/CT diagnosis of multiple myeloma diffuse disease by radiomics analysis.

Mesguich C, Hindie E, de Senneville BD, Tlili G, Pinaquy JB, Marit G, Saut O. Mesguich C, et al. Nucl Med Commun. 2021 Oct 1;42(10):1135-1143. doi: 10.1097/MNM.0000000000001437. Nucl Med Commun. 2021. PMID: 34001823 Free article.

9

Utility of indium-111 platelet scintigraphy for understanding the mechanism of thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia.

Durand P, Pottier V, Mesguich C, Debordeaux F, Lazaro E, Viallard JF, Rivière E. Durand P, et al. Among authors: mesguich c. Exp Hematol Oncol. 2023 May 30;12(1):50. doi: 10.1186/s40164-023-00414-1. Exp Hematol Oncol. 2023. PMID: 37254182 Free PMC article.

10

Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cells.

Galtier J, Vercellino L, Chartier L, Olivier P, Tabouret-Viaud C, Mesguich C, Di Blasi R, Durand A, Raffy L, Gros FX, Madelaine I, Meignin V, Mebarki M, Rubio MT, Feugier P, Casasnovas O, Meignan M, Thieblemont C. Galtier J, et al. Among authors: mesguich c. Haematologica. 2023 Jan 1;108(1):171-180. doi: 10.3324/haematol.2021.280550. Haematologica. 2023. PMID: 35678029 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

26 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year